Evidence map›Paper›PMID 25302964›Full record

ArticlePloS one2014

Measuring and sorting cell populations expressing isospectral fluorescent proteins with different fluorescence lifetimes.

Bryan Sands, Patrick Jenkins, William J Peria, Mark Naivar, Jessica P Houston, Roger Brent

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Autofluorescence lifetime flow cytometry with time-correlated single photon counting.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2024
    Article
  3. Article
  4. Evaluation of Caspase-3 Activity During Apoptosis with Fluorescence Lifetime-Based Cytometry Measurements and Phasor Analyses.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2020
    Article
  5. Article
  6. Fluorescence lifetime shifts of NAD(P)H during apoptosis measured by time-resolved flow cytometry.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2019
    Article
  7. Directed evolution of excited state lifetime and brightness in FusionRed using a microfluidic sorter.Integrative biology : quantitative biosciences from nano to macro · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bryan SandsDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Patrick JenkinsDepartment of Chemical Engineering, New Mexico State University, Las Cruces, New Mexico, United States of America.
William J PeriaDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Mark NaivarDarkling X, LLC, Los Alamos, New Mexico, United States of America.
Jessica P HoustonDepartment of Chemical Engineering, New Mexico State University, Las Cruces, New Mexico, United States of America.
Roger BrentDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

Funding

Research Education About Cancer and Health (REACH) CoreU54CA132381 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Jean Alison McDougall · 2007 to 2026
$25.3M
Undergraduate Student Training in Cancer ResearchU54CA132383 · NCI · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI MICHELE Irene SHUSTER · 2007 to 2026
$21.4M
Systems biology of signal control in yeastR01GM086615 · NIGMS · VTT/MSI MOLECULAR SCIENCES INSTITUTE · PI BRENT, ROGER, YU, RICHARD C. · 2009 to 2012
$2.3M
Dynamics of gradient sensing in single cellsR01GM097479 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRENT, ROGER · 2011 to 2014
$2.1M
NCI NIH HHS U54 CA132381NCI NIH HHS U54 CA132381-06A1NCI NIH HHS U54 CA132383NIGMS NIH HHS R01 GM086615NIGMS NIH HHS R01 GM097479
6 · The paper itself

Abstract

Study of signal transduction in live cells benefits from the ability to visualize and quantify light emitted by fluorescent proteins (XFPs) fused to different signaling proteins. However, because cell signaling proteins are often present in small numbers, and because the XFPs themselves are poor fluorophores, the amount of emitted light, and the observable signal in these studies, is often small. An XFP's fluorescence lifetime contains additional information about the immediate environment of the fluorophore that can augment the information from its weak light signal. Here, we constructed and expressed in Saccharomyces cerevisiae variants of Teal Fluorescent Protein (TFP) and Citrine that were isospectral but had shorter fluorescence lifetimes, ∼ 1.5 ns vs ∼ 3 ns. We modified microscopic and flow cytometric instruments to measure fluorescence lifetimes in live cells. We developed digital hardware and a measure of lifetime called a "pseudophasor" that we could compute quickly enough to permit sorting by lifetime in flow. We used these abilities to sort mixtures of cells expressing TFP and the short-lifetime TFP variant into subpopulations that were respectively 97% and 94% pure. This work demonstrates the feasibility of using information about fluorescence lifetime to help quantify cell signaling in living cells at the high throughput provided by flow cytometry. Moreover, it demonstrates the feasibility of isolating and recovering subpopulations of cells with different XFP lifetimes for subsequent experimentation.

Indexed as

Flow CytometryFluorescenceFluorescent DyesLuminescent ProteinsSaccharomyces cerevisiaeSignal TransductionFluorescent DyesLuminescent Proteins

Identifiers

PMID25302964
PMCPMC4193854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.